Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies.
Bezzio C, Cavalli CAM, Franchellucci G, Dal Buono A, Gabbiadini R, Scalvini D, Manara S, Narcisi A, Armuzzi A, Saibeni S. Bezzio C, et al. Among authors: dal buono a. Therap Adv Gastroenterol. 2024 Nov 21;17:17562848241299564. doi: 10.1177/17562848241299564. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39575159 Free PMC article. Review.
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease.
Parigi TL, Massimino L, Carini A, Gabbiadini R, Bertoli P, Allocca M, Bezzio C, Dal Buono A, D'Amico F, Furfaro F, Loy L, Zilli A, Ungaro F, Jairath V, Peyrin-Biroulet L, Armuzzi A, Danese S. Parigi TL, et al. Among authors: dal buono a. J Crohns Colitis. 2024 Sep 12:jjae145. doi: 10.1093/ecco-jcc/jjae145. Online ahead of print. J Crohns Colitis. 2024. PMID: 39269323
How comparative studies can inform treatment decisions for Crohn's disease.
Privitera G, Bezzio C, Dal Buono A, Gabbiadini R, Loy L, Brandaleone L, Marcozzi G, Migliorisi G, Armuzzi A. Privitera G, et al. Among authors: dal buono a. Expert Opin Biol Ther. 2024 Sep;24(9):955-972. doi: 10.1080/14712598.2024.2389985. Epub 2024 Aug 12. Expert Opin Biol Ther. 2024. PMID: 39132872 Review.
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial.
Ortiz O, Daca-Alvarez M, Rivero-Sanchez L, Gimeno-Garcia AZ, Carrillo-Palau M, Alvarez V, Ledo-Rodriguez A, Ricciardiello L, Pierantoni C, Hüneburg R, Nattermann J, Bisschops R, Tejpar S, Huerta A, Riu Pons F, Alvarez-Urturi C, López-Vicente J, Repici A, Hassan C, Cid L, Cavestro GM, Romero-Mascarell C, Gordillo J, Puig I, Herraiz M, Betes M, Herrero J, Jover R, Balaguer F, Pellisé M; TIMELY study group. Ortiz O, et al. Lancet Gastroenterol Hepatol. 2024 Sep;9(9):802-810. doi: 10.1016/S2468-1253(24)00187-0. Epub 2024 Jul 19. Lancet Gastroenterol Hepatol. 2024. PMID: 39033774 Clinical Trial.
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study.
D'Amico F, Massimino L, Palmieri G, Dal Buono A, Gabbiadini R, Caron B, Moreira P, Silva I, Bosca-Watts M, Innocenti T, Dragoni G, Bezzio C, Zilli A, Furfaro F, Saibeni S, Chaparro M, García MJ, Michalopoulos G, Viazis N, Mantzaris GJ, Ellul P, Gisbert JP, Magro F, Peyrin-Biroulet L, Armuzzi A, Ungaro F, Danese S, Fiorino G, Allocca M. D'Amico F, et al. Among authors: dal buono a. Eur J Clin Invest. 2024 Nov;54(11):e14283. doi: 10.1111/eci.14283. Epub 2024 Jul 9. Eur J Clin Invest. 2024. PMID: 38979834
62 results